Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Miller

Showing results (21-30 of 1,618) with videos related to

Pageof 162
Sort By:
Gene|January 1, 1984
Gene therapy: overregulation may be hazardous to our healthH I Miller
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 1995
A need to "reinvent" the Clinton administration's approach to science and technologyH I Miller
Nature|January 4, 1996
Biosafety regulationsH I Miller
Anesthesia Progress|July 15, 2009
Heart block following syncopeR I Miller
Future Cardiology|October 7, 2009
Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligandYury I Miller
DNA (Mary Ann Liebert, Inc.)|January 1, 1982
Designer genes for producing drugs: will they wash?H I Miller
JAMA|September 24, 1982
Designer genes for producing drugs: will they wash?H I Miller
Nature Biotechnology|February 1, 1997
The end of big government?H I Miller
Human Gene Therapy|April 1, 1993
"Single patient use" and "emergency use" situations in drug review by the Food & Drug AdministrationH I Miller
Human Gene Therapy|November 1, 1995
Overregulation is an unnecessary hindrance to human gene therapyH I Miller
Pageof 162

Showing results (21-30 of 1,618) with videos related to

Sort By:
Pageof 162
Gene|January 1, 1984
Gene therapy: overregulation may be hazardous to our healthH I Miller
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 1995
A need to "reinvent" the Clinton administration's approach to science and technologyH I Miller
Nature|January 4, 1996
Biosafety regulationsH I Miller
Anesthesia Progress|July 15, 2009
Heart block following syncopeR I Miller
Future Cardiology|October 7, 2009
Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligandYury I Miller
DNA (Mary Ann Liebert, Inc.)|January 1, 1982
Designer genes for producing drugs: will they wash?H I Miller
JAMA|September 24, 1982
Designer genes for producing drugs: will they wash?H I Miller
Nature Biotechnology|February 1, 1997
The end of big government?H I Miller
Human Gene Therapy|April 1, 1993
"Single patient use" and "emergency use" situations in drug review by the Food & Drug AdministrationH I Miller
Human Gene Therapy|November 1, 1995
Overregulation is an unnecessary hindrance to human gene therapyH I Miller
Pageof 162